We are live on ! Find out more
KFO

Kopp Family Office Portfolio holdings

AUM $163M
1-Year Est. Return 22.57%
This Fund
S&P 500
This Quarter Est. Return
+41.59%
1 Year Est. Return
+22.57%
3 Year Est. Return
+33.98%
5 Year Est. Return
+1.93%
10 Year Est. Return
AUM
$246M
AUM Growth
+$61.4M
Cap. Flow
-$7.55M
Cap. Flow %
-3.07%
Top 10 Hldgs %
99.97%
Holding
13
New
Increased
1
Reduced
2
Closed

Top Sells

Rank Stock Value
1
NEO icon
NeoGenomics
NEO
+$6.97M
2
XENT
Intersect ENT, Inc
XENT
+$1.29M

Sector Composition

Rank Sector Weight
1 Healthcare 95%
2 Technology 4.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NEO icon
1
NeoGenomics
NEO
$1.96B
$166M 67.51%
3,078,815
-154,200
-5% -$6.97M
VCEL icon
2
Vericel Corp
VCEL
$2.35B
$35.5M 14.47%
1,150,735
HZNP
3
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$32M 13.02%
436,975
+9,510
+2% +$707K
FIVN icon
4
FIVE9
FIVN
$2.11B
$11.6M 4.72%
66,525
XENT
5
DELISTED
Intersect ENT, Inc
XENT
$229K 0.09%
10,000
-67,630
-87% -$1.29M
IVV icon
6
iShares Core S&P 500 ETF
IVV
$878B
$110K 0.04%
292
ISTB icon
7
iShares Core 1-5 Year USD Bond ETF
ISTB
$5.11B
$106K 0.04%
2,050
IEFA icon
8
iShares Core MSCI EAFE ETF
IEFA
$190B
$81K 0.03%
1,178
IAGG icon
9
iShares Core International Aggregate Bond Fund
IAGG
$10.9B
$44K 0.02%
783
IMTB icon
10
iShares Core 5-10 Year USD Bond ETF
IMTB
$275M
$40K 0.02%
764
IJH icon
11
iShares Core S&P Mid-Cap ETF
IJH
$122B
$34K 0.01%
735
IEMG icon
12
iShares Core MSCI Emerging Markets ETF
IEMG
$150B
$20K 0.01%
316
IJR icon
13
iShares Core S&P Small-Cap ETF
IJR
$109B
$19K 0.01%
207

Similar funds

Kopp Family Office's Q4 2020 Portfolio in Review

As of Q4 2020, Kopp Family Office held 13 positions worth $246M, up 33% from $184M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Kopp Family Office withdrew a net $7.55M in Q4 2020, reducing 2 holdings. Its largest reduction was NeoGenomics, cutting an estimated $6.97M.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, up from 94% a quarter earlier, followed by Technology.

Against the trend, Kopp Family Office added an estimated $707K to Horizon Therapeutics Public Limited Company Ordinary Shares.

  • Kopp Family Office added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2020, an estimated $707K increase.
  • Kopp Family Office's biggest Q4 2020 reduction was NeoGenomics, cutting an estimated $6.97M.
  • Kopp Family Office's ten largest holdings make up 100% of its $246M portfolio in Q4 2020.
  • Kopp Family Office opened 0 new positions and closed 0 in Q4 2020.
  • Kopp Family Office's portfolio value rose 33% quarter-over-quarter to $246M.

Based on Kopp Family Office's 13F filing for Q4 2020, filed 16 Feb 2021.